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Abstract: Herba Epimedii is a Chinese herbal medicine with proven efficacy in treating 
cardiovascular diseases and osteoporosis, and in improving sexual and neurological 
functions. This efficacy is found to be related to the potent anti-oxidative ability of Herba 
Epimedii and its flavonoid components, with icarrin as the main effective constituent, 
along with polysaccharides and vitamin C. These ingredients have been proven to be 
effective against oxidative-stress related pathologies (cardiovascular diseases, Alzheimer’s 
disease and inflammation) in animal rodent models and in vitro studies. Their anti-
oxidative properties are found to be related to an inductive effect on endogenous free-
radical scavenging enzymes such as catalase and glutathione peroxidase and the inherent 
electron-donating ability of flavonoids. 
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1. Introduction  
Chinese herbal medicine has been widely used for centuries for the treatment of different diseases. 
The aerial part of Herba Epimedii (Yinyanghuo in Chinese, Figure 1) has long been used for 
“strengthening reproductive function and the skeletal system” [1,2]. In Chinese medicine, Yinyanghuo 
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actually refers to herbs of multiple species. There are five Epimedii species classified under the same 
yinyanghuo herb name, according to the Chinese Pharmacopoeia, namely E. brevicornu Maxim, E. 
koreanum Nakai, E. sagittatim (Sieb & Zucc.) Maxim, E. pubescens Maxim and E. wushanense T.S. 
Ying [3]. On top of that, E. acuminatum Franch and E. leptorrhizum Stearn are also major species in 
Epimedii herb production, and at least 20 species of Epimedii herbs are used on the market [4]. Herba 
Epimedii was proven to be an effective remedy for cardiovascular diseases, osteoporosis and for 
improving sexual and neurological functions [5-7]. It was verified that the effectiveness of Herba 
Epimedii is highly related to its anti-oxidant ingredients. The association of free radical damage and 
oxidative stress with cardiovascular diseases, ageing and neurological defects is well documented 
(Table 1). Thus, it is essential to identify the effective anti-oxidative principles in Herba Epimedii in 
light of the prospect of developing effective drugs against these life-threatening diseases. 
Figure 1. Photo of Herba Epimedii. 
 
 
 
 
 
Table 1. Different Components and Activities of Herba Epimedii. 
Component Anti-oxidative Activity Reference 
Total Flavonoid of 
Epimedium (TFE) 
1. Inhibition of croton oil-induced ear edema and granuloma. 
2. Inhibition of acetic acid-induced vascular permeability. 
3. Inhibition of carrageenin-induced hind paw edema. 
4. Inhibition of primary and secondary inflammation in adjuvant arthritis. 
5. Inhibition of prostaglandin E and malondialdehyde product. 
6. Enhancement of catalase. 
[7] 
7. Protection of H2O2-induced lesions in cardiocytes including inhibition of 
cardiocyte proliferation and increase of cardiocyte apoptosis. 
[8,9] 
Icarrin 1. Protection against free radical-induced damage of DNA. [10] 
2. Protection against free radical-induced peroxidation of polyunsaturated 
fatty acids in low-density lipoprotein and cellular membrane  
[11] 
3. Protection against H2O2-induced cell oxidative injury in vein endothelial 
cells. 
[17] 
4. Protection against β-amyloid neurotoxicity [20,21] 
Polysaccharide 1. Reduction of serum and liver levels of lipoperoxide in aged mice and rats 
and lipofuscin in cardiac muscle of aged mice. 
2. Increase in activities of superoxidase dismutase and glutathione peroxidase 
[23,24] 
Vitamin C 1. Maintainence of normal vasodilatory mechanism controlled by endothelial 
cells. 
2. Reduction of blood pressure. 
3. Enhancement of iron absorption in gastrointestinal tract. 
[25] 
 
Highly-reactive free radicals are by-products in uncoupled electron flow in respiration and they 
rapidly attack molecules in nearby cells and damage lipids in cell membranes, proteins in tissues and 
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DNA. This will result in membrane damage, protein modification and DNA damage and is highly 
related to the ageing process and degenerative diseases such as cancer and heart diseases [8]. 
In human, endogenous anti-oxidative enzymes, such as superoxide dismutase, have evolved to 
prevent the accumulation of free-radicals by metabolizing the free-radicals formed. However, this 
protection is always far from being sufficient. Anti-oxidants from herbal sources can provide 
additional power to enhance our bodies’ ability in combating free radicals formed in the body. 
Flavonoids are formed in plants from aromatic amino acids like phenylalanine and tyrosine. 
Flavonoids work as anti-oxidants by increasing the level of enzymes responsible for metabolism of 
free-radicals and act as anti-oxidants by virtue of the electron-donating group of flavonoids. By these 
mechanisms, Herba Epimedii combats free-radicals and induces different mechanisms against 
pathological situations [8]. In this review, we will cover research progress in the pharmacology of 
Herba Epimedii and its components. 
2. Anti-Oxidizative effect of different ingredients in Herba Epimedii 
The main constituents of Herba Epimedii are flavonoids, an important class of natural anti-oxidants. 
Therefore, the Total Flavonoid of Epimedium (TFE) has been well investigated for its antioxidant 
properties (Table 1). Among the flavonoids present in Herba Epimedii, icarrin (Figure 2) is recognized 
as the major pharmacologically active component [9] and has been further extracted for detailed 
studies. Besides, other components such as polysaccharides and vitamin C also contribute to the anti-
oxidative ability of Herba Epimedii in different organs. In the following sections, the different 
components of Herba Epimedii will be discussed. 
 
Figure 2. Icarrin (2-(4’-methoxyphenyl)-3-rhamnosido-5-hydroxyl-7glucosido-8-(3’-
methyl-2-butylenyl)-4-chromanone). 
 
2.1. Total flavonoids of Epimedium 
By using column chromatography, flavonoids were isolated from Herba Epimedii of different 
origins. From E. wushanense, diphylloside A, epimedoside A, epimedin C, icarrin, epimedoside C, 
icarisoside A and desmethylanhydroicaritin have been isolated [10]. The content of TFE varies 
according to spieces, geographical origin [11,12] or time of harvest of the herbs [12]. It is reported that 
 
Molecules 2010, 15                            
 
 
7864
more than 60 different flavoind compounds can be isolated from Herba Epimedii [13]. In-depth 
research into the flavonoid content of Herba Epimedii has been conducted by researchers in mainland 
China. Zhou et al. reported the TFE content in four speices of herba epimedii, namely E. pubescens 
Maxim, E. koreanum Nakai, E. brevicomum Maxim and E. sagittatum (Sieb. et Zucc.) Maxim which 
ranged from 29.72 mg/g to 82.63 mg/g (around 2.972% to 8.263%) depending on the speices and 
source of herbs [11]. Other research reported a TFE content ranging from 0.927% to 15.2% in nine 
speices of epimedium herbs depending, as mentioned, on the particular species, harvesting time and 
source of origin [12]. 
 
2.1.1. Anti-oxidative effect in anti-inflammatory effects of total flavonoid of Epimedium (TFE) 
TFE is observed to inhibit the chronic and acute inflammatory effects in mice. Inflammatory 
pathologies such as ear edema and granuloma induced by croton oil, increased vascular permeability 
induced by acetic acid and hind paw edema induced by carrageenin are all significantly inhibited by 
TFE. TFE also exerts a suppressive action on primary and secondary inflammation in adjuvant 
arthritis. This anti-inflammatory ability of TFE is believed to be related to its anti-oxidant ability. TFE 
significantly inhibits prostaglandin E and the metabolic product of lipid peroxidation, malondialdehyde 
(MDA) and also enhances the activity of free-radical scavenging enzyme, catalase (CAT), in murine 
erythrocytes [14]. 
2.1.2. Anti-oxidative effect of total flavonoids of Epimedium(TFE) in cardiocytes 
TFE exerts a protective effect against cardiocyte lesions induced by H2O2. The cardiocytes are 
isolated from neonatal rats and subsequently culture in vitro. The proliferative status of cardiocytes 
under the influence of H2O2 and TFE is studied by MTT proliferation assay. Also, apoptosis of 
cardiocytes is studied by flow cytometry and the morphological changes are observed under a 
transmission electron microscope. Treatment with H2O2 leads to inhibition of cardiocyte proliferation 
in a dose-dependent way and changes the cardiomyocyte ultrastructure such as nuclear fragmentation. 
The apoptotic rate is (23.94 ± 3.52)%, which is higher than that of control cells (1.98 ± 1.22%) at 
twelve hours after administration of H2O2. Treatment of TFE is able to reverse the apoptotic effect of 
cardiocytes at the doses of 100, 200 and 400 mg/L respectively [(15.12 ± 3.01)% , (9.38 ± 3.14) % and 
(4.49 ± 0.52)% cells undergoing apoptosis] [15]. 
Another animal experiment also illustrates the protective effect of TFE on the heart in acute 
myocardial anoxia. The mean survival time and capacity of cardiac oxygen consumption under 
ordinary pressure in mice are recorded and time of disappearance of electrocardiographic sign is 
measured after clamping the trachea. TFE administration prior to the experiment is capable of 
prolonging the mean survival time and decreasing the time of disappearance of electrocardiographic 
sign [16]. 
 
2.2. Icarrin 
Icarrin (ICA) is a flavonoid with structural formula C33H40O15 and molecular weight of 676.67. It is 
suggested that the icarrin is the major bioactive components and exists in many speices of Epimedii 
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plants. The discovery of icarrin from the species E. macranthum Morr et Decne by Japanese 
researchers can be traced back to 1935 [17]. Its content in Herba Epimedii has been reported by 
different groups. Like TFE, the content of icarrin varies among species and sources. The icarrin  
content ranged from 0 to 2.732% among nine species, in which the E. pubescens Maxim showed the 
highest content, while E. leptorrhizum Stearn showed none [12]. Another group reports the flavonoid 
content from 17 species, in which icarrin content ranged from 0–14.24 mg/g [18]. This suggests certain 
kinds of Epimedii plants may serve as better herbal materials for pharmaceutics purposes.  
 
2.2.1. Anti-oxidative effect of icarrin on radical-induced oxidative damage of DNA 
Icarrin protects DNA against radical-induced oxidative damage in a concentration-dependent 
manner. In the experiment, the oxidative damage of DNA is measured by the formation of carbonyl 
compounds that can react with thiobarbituric acid (TBA) to form thiobarbituric acid reactive substance 
(TBARS) [19]. 
 
2.2.2. Anti-oxidative effect of icarrin against free-radical-induced peroxidation of polyunsaturated fatty 
acids in low-density lipoprotein and cellular membrane 
Icarrin protects polyunsaturated fatty acids in erythrocyte cellular membrane and prevents 
erythrocytes from undergoing haemolysis. Erythrocyte membranes contain abundant polysaturated 
fatty acids that are prone to peroxidation by free-radicals generated from the decomposition of a water-
soluble azo compound, 2,2’-azobis(2-amidinopropane hydrochloride) (AAPH). The degree of 
peroxidation is measured by the haemoglobin concentration outside the erythrocytes. It is found that 
icarrin dose-dependently protects erythrocytes against free-radical peroxidation, which is attributed to 
the presence of hydroxyl group at the 5-position when the anti-oxidative activities of structural analogs 
are compared [20]. 
 
2.2.3. Anti-oxidative effects of icarrin on vein endothelial cell oxidative injury induced by H2O2 
Icarrin is able to reduce the extent of oxidative injury in endothelial cells. Oxidative injury induced 
by ischemia/ hypoxia, reperfusion and inflammation can lead to cardiac and endothelial cell apoptosis 
[21-24]. Such apoptosis of endothelial cells would disrupt the integrity of the endothelium monolayer 
that is crucial to prevent vascular leakage and formation of atherosclerosis [25]. In the experiment, 
eighteen-hour treatment with 750 µmol L-1 H2O2 significantly reduces the viability of human  
umbilical vein ECV-304 endothelial cells and induces apoptotic features such as distinct 
morphological alteration and increases caspase-3 expression. Pretreatment with icarrin reverses the 
injury and apoptosis in a dose-dependent manner and the expression of caspase-3 is also reduced [26]. 
 
2.2.4. Anti-oxidative effects against neurotoxicity of β-amyloid 
Icarrin is found to inhibit the neurotoxicity of β-amyloid peptide, which is a neurotoxic species 
associated with the pathogenesis of Alzheimer’s disease (AD). It enters the mitochondria to induce the 
generation of reactive oxygen species and subsequent free-radical attacks on protein, DNA, RNA and 
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lipid. This eventually leads to neuronal death [27,28]. The ability of spatial learning and memory of the 
animals is tested by using Morris water maze. Icarrin significantly decreases the mean escape latency 
and searching distance in place navigation test while it also increases the searching time and searching 
distance in the quadrant in comparison to mice unilaterally injected with amyloid β-protein. Through 
immunohistochemistry and real time RT-PCR analysis, it discloses that icarrin significantly decreases 
the content of β-amyloid and mRNA levels of β-secretase in the hippocampus, which is a key enzyme 
in generation of β-amyloid peptide from amyloid precursor protein. Also, mRNA level of an 
antioxidant enzyme, superoxide dismutase-2, is increased in the presence of icarrin [29]. 
Another experiment reveals the protective ability of icarrin against neurotoxicity of β-amyloid by 
up-regulating cocaine-regulated and amphetamine-regulated transcripts. Also, this up-regulation is 
dependent on the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) 
pathway. In the experiment, mRNA and protein levels of cocaine and amphetamine-regulated 
transcript (CART) are increased in neuronal culture pretreated with β-amyloid peptide. This induction 
and protective effect are suppressed by extracellular signal-regulated kinase inhibitor and CART-RNA 
interference. This further experiment explores the mechanism and pathway involved in the 
neuroprotective action of icarrin [30]. 
Icarrin protects against cognitive deficits induced by chronic cerebral hypofusion in rats through its 
antioxidant effects,and effects on the circulatory and cholinergic systems [31]. It inhibits release of 
reactive oxygen species, nitric oxide, prostaglandin E and mRNA expression of proinflammatory 
cytokines in microglia [32]. 
2.3. Polysaccharides 
Polysaccharides in Herba Epimedii are composed of monosaccharides including mannose, glucose, 
6-deoxymannose, galactose, arabinose and galacturonic acid. The polysaccharide content varies among 
Herba Epimedii of different origins, ranging from 18.64% to 31.11% [33]. 
2.3.1. Anti-oxidative effect of polysaccharide 
Polysaccharides increase the anti-oxidant ability of erythrocytes by increasing the activities of 
intracellular key enzymes responsible for scavenging free-radicals [34]. In one experiment, male 
Sprague-Dawley rats are employed to investigate the effect of polysaccharide for consecutive 50-day 
treatment. Polysaccharides help reduce the serum and liver content of lipoperoxide (LPO) in aged mice 
and rats, together with the content of lipofuscin (LF) in cardiac muscle of aged mice [34]. These two 
parameters reflect the lipid oxidation level. The higher level of LF in cardiac muscle, the higher is the 
level of oxidation of lipid. 
Superoxidase dismutase (SOD) and glutathione peroxidase (GSH-Px) activity levels are also 
increased after administration of the polysaccharide [34]. The two enzymes are important in 
scavenging free-radicals inside the cells. It is also found that SOD activity is induced in chickens in a 
dose-dependent manner [35]. 
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2.4. Vitamin C 
Vitamin C has long been known as an effective natural antioxidant given its electron-donating 
property. The anti-oxidant properties of vitamin C have been established in in vitro experiments [36]. 
Vitamin C is a significant component in Herba Epimedii and contributes to the anti-oxidant properties 
of Herba Epimedii. Vitamin C in Herba Epimedii is determined by ultraviolet spectrophotometry at 
243 nm. 1.0% HCl solution is used for extraction of vitamin C from Epimedium leaves. A variation of 
the contents of vitamin C is found among the cultivated samples of Herba Epimedii from different 
sources (E. sagittatum, E. myrianthum and E. doluchostemon) [37]. The importance of vitamin C has 
only been demonstrated in prevention of life-threatening scurvy disease in clinical studies. However, 
pre-clinical investigations employing in vitro experiments suggest the importance of vitamin C in 
maintaining normal vasodilatory mechanism controlled by endothelial cells, low blood pressure and 
enhancement of iron absorption in gastrointestinal tract [36]. The role of vitamin C as an anti-oxidant 
in Herba Epimedii is yet to be explored in the future. 
In addition to the aforementioned activities, flavonoids from E. brevicomum prevents bone loss in 
postmenopausal women [38]. An aqueous extract of E. saggittatum prevents ovariectomy-induced 
bone loss in rats [39]. Total flavonoids of Herba Epimedii increase the expression of core binding 
factor alpha 1 which regulates the differentiation of osteoblastic precursors and activity of mature 
osteoblasts [40]. A water extract of Herba Epimedii lowers serum levels of total cholesterol and 
triglycerides, but elevates serum estradiol levels in postmenopausal women [41]. Well processed 
Herba Epimedii improves sexuality in male rats [42]. Icariside II from E. koreanum roots has 
antioxidant activity and inhibits melanogenesis and induces apoptosis in human PC-3 prostate cancer 
cells [43].  
3. Conclusions 
Numerous studies have established the anti-oxidative ability of Herba Epimedii against different 
oxdative stress conditions in vitro and in vivo. The ability of flavonoids to increase antioxidation 
enzymes and inhibit lipid peroxdiation product has be verified in murine erythrocytes. TFE is also able 
to reduce the cardiocytes lesion induced by H2O2 and exerts protective effect on the heart in acute 
myocardial anoxia. Icarrin, as a major bioactive component, is also demonstrated to protect against 
radical induced damage to DNA and peroxidation of polyunsaturated fatty acids. Protective effects of 
icarrin on the H2O2 induced stress and neuroprotection against β-amyloid was also reported. The 
stimulation of enzymes responsible for scavenging of free radicals and antioxidation by 
polysaccharides from Epimedii also add value to the pharmaceutical potential of the herb. Further 
clinical applications of this traditional herbal medicine may be developed on the basis of these 
pharmacological mechanisms found in in vivo and in vitro. Diseases related to oxidative-stress may 
also serve as target for further research. 
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